CD160
Summary: CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine-rich, glycosylphosphatidylinositol-anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. CD160 is expressed at the cell surface as a tightly disulfide-linked multimer. RNA blot analysis revealed CD160 mRNAs of 1.5 and 1.6 kb whose expression was highly restricted to circulating NK and T cells, spleen and small intestine. Within NK cells CD160 is expressed by CD56dimCD16+ cells whereas among circulating T cells its expression is mainly restricted to TCRgd bearing cells and to TCRab+CD8brightCD95+CD56+CD28-CD27-cells. In tissues, CD160 is expressed on all intestinal intraepithelial lymphocytes. CD160 shows a broad specificity for binding to both classical and nonclassical MHC class I molecules. [provided by RefSeq, Jul 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
NameCD160 molecule OMIM IDMIM:604463 Ensembl IDEnsembl:ENSG00000117281 HGNC IDHGNC:HGNC:17013 PHARMGKB IDPA134943137 Map Location1q21.1 |
Gene Categories:
DRUGGABLE GENOMEGO terms in CD160
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IDA | GO:0005102 | signaling receptor binding |
MF | IPI | GO:0005515 | protein binding |
MF | IDA | GO:0032393 | MHC class I receptor activity |
MF | TAS | GO:0038023 | signaling receptor activity |
CC | TAS | GO:0005886 | plasma membrane |
CC | IBA | GO:0046658 | anchored component of plasma membrane |
Gene expression in normal tissue: CD160
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CD160
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-1280218 | Adaptive Immune System |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-198933 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
Gene-Drug: Aster Plot
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in CD160
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |